Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

2PMW

The Crystal Structure of Proprotein convertase subtilisin kexin type 9 (PCSK9)

2PMW の概要
エントリーDOI10.2210/pdb2pmw/pdb
分子名称Proprotein convertase subtilisin/kexin type 9, SULFATE ION, ... (4 entities in total)
機能のキーワードpropeptide, subtilisin, protease, hydrolase
由来する生物種Homo sapiens (human)
詳細
タンパク質・核酸の鎖数2
化学式量合計71657.61
構造登録者
Piper, D.E.,Romanow, W.G.,Thibault, S.T.,Walker, N.P.C. (登録日: 2007-04-23, 公開日: 2007-05-08, 最終更新日: 2024-10-30)
主引用文献Piper, D.E.,Jackson, S.,Liu, Q.,Romanow, W.G.,Shetterly, S.,Thibault, S.T.,Shan, B.,Walker, N.P.
The Crystal Structure of PCSK9: A Regulator of Plasma LDL-Cholesterol.
Structure, 15:545-552, 2007
Cited by
PubMed Abstract: Proprotein convertase subtilisin kexin type 9 (PCSK9) has been shown to be involved in the regulation of extracellular levels of the low-density lipoprotien receptor (LDLR). Although PCSK9 is a subtilase, it has not been shown to degrade the LDLR, and its LDLR-lowering mechanism remains uncertain. Here we report the crystal structure of human PCSK9 at 2.3 A resolution. PCSK9 has subtilisin-like pro- and catalytic domains, and the stable interaction between these domains prevents access to PCSK9's catalytic site. The C-terminal domain of PCSK9 has a novel protein fold and may mediate protein-protein interactions. The structure of PCSK9 provides insight into its biochemical characteristics and biological function.
PubMed: 17502100
DOI: 10.1016/j.str.2007.04.004
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 2pmw
検証レポート(詳細版)ダウンロードをダウンロード

248335

件を2026-01-28に公開中

PDB statisticsPDBj update infoContact PDBjnumon